People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Metagenics, Inc. | — | Other Health Care | Series B | $28.1M | $622.5M | 2009 |
David Fetah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Fetah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yee-Ping ` Chu | 1 | 2 |
| Jeffrey Bland | 1 | 2 |
| Robert Hovee | 1 | 1 |
| Michael Leiner | 1 | 1 |
| Jerry Morey | 1 | 1 |
| John Zaepfel | 1 | 1 |
| Paul Konney | 1 | 1 |
| David Krajanowski | 1 | 1 |
| Jeffrey Katke | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.